Yuxiang Wang | Molecular Biology | Best Researcher Award

Posted on by Cell Biologist

Dr. Yuxiang Wang | Molecular Biology | Best Researcher Award

Dr. Yuxiang Wang, Fudan University, China

Dr. Yuxiang Wang is a Principal Investigator and Ph.D. Supervisor at Fudan University, with an extensive background in molecular biology, oncology, and translational medicine. He earned his Ph.D. in Developmental and Molecular Biology from the Albert Einstein College of Medicine, where he worked under the mentorship of Dr. Jeffrey W. Pollard. Following this, he completed a prestigious research fellowship at Memorial Sloan-Kettering Cancer Center. Dr. Wang has built a strong academic and clinical research portfolio, focusing on gliomas and muscular dystrophy. His work utilizes state-of-the-art preclinical models and CRISPR screening technologies to identify novel therapeutic strategies. Dr. Wang is a recipient of numerous honors, including the MSK Society Scholar Award and Shanghai Leading Overseas Talent recognition. He actively collaborates with clinicians to translate lab discoveries into patient therapies, and his prolific publication record reflects deep scientific rigor and innovation.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Strong Research Track Record
    Dr. Wang has published in top-tier journals such as Nature Communications, Science Advances, Cancer Research, and PNAS. His publication record demonstrates consistency, depth, and high impact across multiple domains including glioma biology and gene therapy.

  2. Dual Research Focus
    He leads research in two distinct yet critical biomedical areas—malignant gliomas and muscular dystrophy. This breadth shows versatility and the ability to manage complex translational programs.

  3. Innovative Techniques
    Dr. Wang effectively applies CRISPR-based genetic screening, preclinical mouse models, and patient-derived cell lines—cutting-edge tools that reflect a forward-thinking, high-tech research approach.

  4. International Research Background
    His training and professional experience in both the U.S. (at Memorial Sloan-Kettering Cancer Center) and China make him a bridge between Western and Eastern biomedical research ecosystems.

  5. Leadership and Mentorship
    Serving as both Principal Investigator and Ph.D. Supervisor, and having been Vice Director at a major clinical research center, Dr. Wang shows strong leadership and a commitment to research training.

  6. Recognitions and Awards
    Prestigious honors such as the Shanghai Leading Overseas Talent, Shanghai Pujiang Talent, and MSK Society Scholar Award (twice) underline peer recognition and scientific excellence.

🛠️ Areas for Improvement:

  1. Clinical Translation and Implementation
    While his preclinical work is strong, more details or evidence on how these findings have progressed toward clinical trials or therapeutic products could further strengthen his translational profile.

  2. Interdisciplinary Collaborations
    Expanding collaborations across fields like bioengineering, immunotherapy, or computational biology may add further value and broaden research impact.

  3. Visibility and Outreach
    Increasing visibility through keynote lectures, patents, or public datasets could enhance his reputation globally and support broader dissemination of his work.

  4. Grants and Funding Portfolio
    While not detailed in the CV, highlighting national/international grant leadership or participation would provide insight into his ability to secure and manage competitive research funding.

🎓 Education:

Dr. Yuxiang Wang holds a distinguished academic background across leading institutions. He completed his Ph.D. in Developmental and Molecular Biology at Albert Einstein College of Medicine (2008–2014), under Dr. Jeffrey W. Pollard, focusing on hormone signaling and uterine biology. Before that, he earned a Master of Sciences from Fudan University (2004–2007), mentored by Dr. Bo Chen, where he explored hormone interactions in reproductive biology. He began his academic journey with a Bachelor of Sciences from the Ocean University of China (2000–2004), majoring in life sciences. This robust education laid the foundation for his later success in cancer biology and translational research. Throughout his academic path, Dr. Wang has demonstrated a consistent focus on the cellular and molecular mechanisms underlying human diseases, especially cancer and genetic disorders. His education, blending rigorous laboratory work and clinical relevance, has uniquely positioned him for cutting-edge biomedical research.

💼 Experience:

Dr. Wang currently serves as Principal Investigator and Ph.D. Supervisor at Fudan University’s School of Basic Medical Sciences (2020–present), where he leads research on gliomas and muscular dystrophy. From 2021 to 2023, he also held the position of Vice Director of the Research Department at the Clinical Research Center of the Affiliated Children’s Hospital of Fudan University, coordinating clinical and translational projects. Prior to his return to China, Dr. Wang worked as a Research Fellow at Memorial Sloan-Kettering Cancer Center (2015–2020), collaborating with Dr. Timothy Chan and Dr. Jason Huse on the molecular basis of brain tumors and treatment resistance. His career bridges fundamental science and clinical applications, with a focus on leveraging genetic models and CRISPR technologies to uncover therapeutic targets. Dr. Wang’s international experience and leadership in high-impact research programs underscore his contributions to biomedical innovation and mentorship.

🏅 Awards and Honors:

Dr. Yuxiang Wang’s outstanding scientific contributions have been recognized through several prestigious awards. He was named a Shanghai Leading Overseas Talent (2020) and a Shanghai Pujiang Talent (2020), highlighting his excellence in international scientific exchange and leadership. While at Memorial Sloan-Kettering Cancer Center, he was twice awarded the MSK Society Scholar Award (2018, 2019), which recognizes exceptional postdoctoral researchers demonstrating strong potential for independent academic careers. These accolades underscore Dr. Wang’s commitment to impactful research, innovation in therapeutic development, and mentorship of young scientists. His ability to translate fundamental research into preclinical and potentially clinical solutions sets him apart as a research leader. These honors reflect peer recognition of both the depth and translational potential of his work in oncology and genetic diseases.

🔬 Research Focus:

Dr. Wang’s research centers on two critical areas: malignant gliomas and muscular dystrophy. In glioma studies, his team investigates the cooperative role of IDH and ATRX mutations using CRISPR-based genetic screening in mouse models to identify synthetic lethal targets—genes whose inhibition can selectively kill tumor cells with specific mutations. This strategy opens doors to novel, mutation-specific therapies with minimal harm to healthy cells. In muscular dystrophy, Dr. Wang focuses on rare genetic mutations affecting glycosylation pathways, utilizing patient-derived cells and animal models to evaluate gene therapy and genome editing solutions. His work seeks not only to understand disease mechanisms but also to bridge the lab-to-clinic gap. A long-term objective is to offer personalized therapies for patients with genetically defined diseases. The integration of molecular biology, translational research, and therapeutic innovation defines his approach.

📚 Publication Top Notes: 

  1. 🧬 Genetically Engineered Mouse Models Unveil Mechanisms and Therapeutic Strategies for GMPPB-Associated Dystroglycanopathy – Nature Communications (under revision)

  2. 🧠 PRICKLE4 Underlies IDH mutant Tumor Resistance against PARP Inhibition – Advanced Science (under revision)

  3. 🧫 Comprehensively characterizing eRNA in immune cells to screen combinational strategies for anti-cancer immunotherapy – Cancer Research (2025)

  4. 🔬 Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas – Science Advances

  5. 🧬 G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma – Nature Communications

  6. 🧪 Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence – Nature Genetics

  7. 🧠 Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling – Nature Communications

  8. 🧬 Activation of protein synthesis in mouse uterine epithelial cells by estradiol-17β is mediated by a PKC–ERK1/2–mTOR signaling pathway – PNAS

  9. 🔬 GSK-3β mediates in the progesterone inhibition of estrogen-induced cyclin D2 nuclear localization and cell proliferation in cyclin D1−/− mouse uterine epithelium – FEBS Letters

🧾 Conclusion:

Dr. Yuxiang Wang is a highly deserving candidate for the Best Researcher Award. He demonstrates:

  • A clear and sustained record of scientific excellence,

  • Deep expertise in cancer biology and rare disease genetics,

  • Use of innovative methodologies, and

  • Leadership in both academic and clinical research environments.

His contributions to understanding the molecular basis of gliomas and developing targeted therapies for muscular dystrophy have significant implications for personalized medicine. With continued development in clinical translation and interdisciplinary reach, he stands out as a leader of the next generation of biomedical scientists.

SWATI SHARMA | Microbial Cell Biology | Best Researcher Award

Posted on by Cell Biologist

Dr. SWATI SHARMA | Microbial Cell Biology | Best Researcher Award

Dr. SWATI SHARMA, University of Birmingham, United Kingdom

Dr. Swati Sharma is a highly accomplished researcher in environmental remediation, currently serving as a Marie Curie Postdoctoral Fellow at the University of Birmingham, UK. With deep expertise in microbiology, nanotechnology, and biochemical sciences, her work focuses on sustainable solutions to pollution through advanced bioengineering techniques. Dr. Sharma has consistently demonstrated excellence in both academia and research, with over 1,200 citations and a cumulative impact factor exceeding 80. Her scientific journey began in India, where she earned her Ph.D. from the prestigious Indian Institute of Technology (IIT) Guwahati. Her dedication to multidisciplinary collaboration has led to innovative advances in biosurfactants, nanomaterials, and microbial bioremediation. Through her impactful publications and international collaborations, Dr. Sharma is building a globally recognized research profile aimed at addressing some of the most critical environmental challenges.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. International Recognition & Funding

    • Marie Curie Fellowship—a highly competitive and prestigious EU-funded postdoctoral program.

  2. High-Impact Publications

    • 23 peer-reviewed journal articles across top-tier journals (e.g., Chemical Engineering Journal, Bioresource Technology).

  3. Strong Research Metrics

    • Over 1200 citations, indicating significant impact and recognition in the field.

  4. Interdisciplinary Excellence

    • Research spans biotechnology, nanoscience, environmental engineering, and materials science.

  5. Innovation in Sustainability

    • Developed eco-friendly technologies for oil spill remediation, heavy metal detoxification, and biosurfactant production.

  6. Proven Teaching & Mentoring

    • Experience as Teaching Assistant in critical subjects like Biophysics, Biochemical Engineering, and Research Methodology at IIT Guwahati.

🔍 Areas for Improvement:

  1. Industry Collaboration & Technology Transfer

    • Could further enhance her profile through patents, start-ups, or partnerships with environmental technology companies.

  2. Leadership in Global Research Networks

    • Building roles in international research consortia, editorial boards, or scientific committees would increase visibility and influence.

  3. Public Engagement & Outreach

    • Increased involvement in science communication, outreach programs, or policy advocacy would broaden the societal impact of her research.

🎓 Education:

Dr. Swati Sharma’s academic foundation is rooted in premier Indian institutions known for excellence in science and engineering. She earned her Ph.D. in Biosciences and Bioengineering from the Indian Institute of Technology (IIT) Guwahati in 2022, where she focused on microbial remediation and biosurfactant applications. Prior to her doctoral studies, she obtained her M.Tech. in Biotechnology from the National Institute of Technology (NIT) Durgapur in 2016, building her technical and analytical skills in applied biological sciences. Her undergraduate journey began with a B.E. in Biotechnology from RV College of Engineering, Bangalore in 2014, where she was introduced to biochemical engineering and environmental biotechnology. This robust educational background has equipped her with interdisciplinary expertise, integrating biological sciences, nanotechnology, and environmental engineering to tackle global pollution problems through innovative, research-driven solutions.

👩‍🔬 Experience:

Dr. Swati Sharma has extensive experience in research and academia, particularly in biotechnology and environmental sciences. She is currently a Marie Curie Postdoctoral Fellow at the University of Birmingham, where she is investigating advanced bioremediation and nanotechnology applications for pollution control. From 2017 to 2019, she served as a Teaching Assistant at IIT Guwahati, contributing to undergraduate and postgraduate education in Research Methodology, Biophysics, and Biochemical Engineering. Her hands-on experience in reactor design, biosurfactant production, and wastewater treatment has been complemented by collaborative projects with chemical engineers, microbiologists, and materials scientists. Dr. Sharma has also worked in pilot-scale bioreactors and conducted field studies on oil-spill remediation. Her integrated research and teaching background showcase her versatility, communication skills, and a strong commitment to mentoring future scientists while pushing the boundaries of environmental and biochemical research.

🔬 Research Focus:

Dr. Swati Sharma’s research centers on environmental remediation using biosurfactants, nanomaterials, and microbial consortia. Her primary focus lies in the biodegradation of hydrocarbons, heavy metals, and dyes using engineered microbial systems and green nanotechnology. She has developed and optimized bioprocesses for oil-spill cleanup, wastewater treatment, and pathogen control, including innovative reactor configurations and biosorption mechanisms. Dr. Sharma’s work is interdisciplinary, spanning biotechnology, chemical engineering, and material sciences—with a strong emphasis on sustainability. She explores the synergy between biosorption and biodegradation, enabling cost-effective and scalable remediation systems. Her recent projects involve the use of tungsten-oxide nanomaterials for hydrogen evolution and the disinfection of viral pathogens like SARS-CoV-2 through novel physical methods. Through high-impact research and global collaborations, she aims to bridge the gap between lab-scale discoveries and real-world environmental solutions.

📚 Publications Top Notes: 

  1. 🦴 Design of biphasic Fe and Zn doped hydroxyapatite to combat osteomyelitis – Ceramics Int.

  2. 🌱 Enhanced biosurfactant production by Bacillus subtilis using molasses – J. Biotech

  3. 🛢️ Biodegradation kinetics of Hexadecane & Phenanthrene via microconsortium – Bioresource Tech

  4. ⚡ Bulk synthesis of WO₃ nanomaterials for wastewater and hydrogen generation – Chem Eng J

  5. 🦠 UV-C & IR disinfection of SARS-CoV-2 spike protein – Int. J. Biol. Macromol

  6. 🧽 Hydrophobic biosorption & microbial remediation of oil spills – Ind Eng Chem Res

  7. 🛢️ Fed-batch integration of biosorption and biodegradation for oil cleanup – Lett Appl Microbiol

  8. 🍳 Waste cooking oil biodegradation & rhamnolipid production – Bioproc Biosyst Eng

  9. 🌿 Fungal bioherbicides for water hyacinth control – J. Basic Microbiol

  10. 🛢️ Biosurfactant production from sludge-isolated Bacillus subtilis – Bioresource Tech

🧾 Conclusion:

Dr. Swati Sharma is an outstanding early-career researcher whose academic rigor, international fellowship recognition, and impactful research position her as a strong and deserving candidate for the Best Researcher Award. Her work addresses urgent global environmental problems using an integrative and innovative scientific approach, bridging fundamental research and applied environmental biotechnology. Given her achievements to date and her potential for continued excellence and leadership, she merits serious consideration for this honor.

Eunmiri Roh | Molecular Mechanisms Signaling | Best Researcher Award

Posted on by Cell Biologist

Prof. Eunmiri Roh | Molecular Mechanisms Signaling | Best Researcher Award

Prof. Eunmiri Roh, Department of Cosmetic Science, Kwangju Women’s University, South Korea

Dr. Eunmiri Roh is an accomplished biomedical scientist and Assistant Professor in the Department of Cosmetic Science at Kwangju Women’s University, Republic of Korea. With a strong foundation in microbiology and pharmaceutical sciences, Dr. Roh has established herself in the field of skin cancer biology and cosmetic science. Her research explores cellular and molecular pathways in skin carcinogenesis, melanogenesis, photoaging, and chemoprevention, emphasizing UV-induced damage and pigmentation disorders. She has published extensively in top-tier international journals and has collaborated with leading institutions, including the University of Minnesota. Dr. Roh’s dedication to integrating science with practical beauty and health solutions positions her as a leading figure in her field. Her exceptional contributions have earned her multiple research honors, and she continues to innovate at the intersection of pharmaceutical science and cosmetology.

Publication Profile:

Google Scholar

Orcid

✅ Strengths for the Award:

  1. High-Impact Research Portfolio
    Dr. Roh has produced a consistent stream of peer-reviewed publications in high-impact international journals, such as Biochemical Pharmacology, Cancer Research, Journal of Investigative Dermatology, and Cells, reflecting her solid global research presence.

  2. Focused and Societally Relevant Research
    Her primary focus—UV-induced skin carcinogenesis, pigmentation disorders, and chemoprevention—addresses pressing issues in dermatology and cosmetic health, aligning with public health interests and the cosmetic industry’s innovation goals.

  3. Interdisciplinary Expertise
    Dr. Roh’s training in biochemistry, pharmacy, and microbiology supports a multidisciplinary research approach, which is evident in her collaboration with dermatologists, chemists, and pharmacologists.

  4. Award-Winning Excellence
    She has earned multiple national and international research awards, including from the Korean Society of Microbiology and Biotechnology, the Korean Society of Cancer Prevention, and The Hormel Institute (USA), validating her scientific merit.

  5. Strong International Collaboration
    Collaboration with globally recognized institutions like the University of Minnesota and The Hormel Institute reflects the international relevance and applicability of her research.

  6. Translational Research Impact
    Dr. Roh’s research bridges basic science and application—discovering bioactives for cosmetics and drug delivery systems, highlighting practical impact in dermatology and consumer health.

⚙️ Areas for Improvement:

  1. Leadership in Independent Grants
    While publication output is impressive, securing independent competitive research funding (e.g., national research grants, PI-led international projects) would further reinforce her research leadership.

  2. Mentorship and Academic Development
    Enhanced documentation of her mentorship role—particularly training graduate students, Ph.D. candidates, or postdoctoral researchers—would highlight her academic influence beyond publications.

  3. Commercial Translation or Patents
    Filing patents or commercializing products/formulations related to her discoveries (e.g., natural anti-pigmentation agents or UV protectants) could amplify her impact and innovation metrics.

  4. Greater Engagement in Scientific Leadership
    Increased visibility in scientific committees, editorial boards, or as a conference keynote speaker would establish her as a thought leader in her field.

📘 Education:

Dr. Roh’s academic journey began with a Bachelor of Science in Microbiology from the College of Natural Sciences at Chungbuk National University (2007). Motivated to delve deeper into biomedical research, she pursued her Master’s degree in Life Pharmacy (2009), followed by a Ph.D. in Pharmaceutical Function with a focus on biochemistry (2012) at the College of Pharmacy in the same university. Her graduate and doctoral training provided her with a robust understanding of molecular biology, pharmacology, and biochemical mechanisms, forming the backbone of her current work in dermatological science and cosmetic pharmacology. The interdisciplinary nature of her studies laid the groundwork for her specialization in skin biology, UV-induced skin damage, and pigmentation-related drug discovery. Her academic foundation is both broad and deep, equipping her with the necessary tools to explore innovative solutions for skin health through cosmetic science.

🧪 Experience:

Dr. Eunmiri Roh currently serves as an Assistant Professor at the Department of Cosmetic Science, Kwangju Women’s University, where she leads research on cosmetic pharmacology, focusing on skin cancer prevention and pigmentation disorders. Before joining academia, she gained valuable research experience at globally recognized institutions such as The Hormel Institute, University of Minnesota, where she was awarded for outstanding scientific contributions. She has collaborated in multidisciplinary teams working on skin photoaging, UV protection, anti-inflammatory pathways, and novel cosmetic drug formulations. Her work spans in vitro and in vivo studies, biochemical analysis, and formulation science. Dr. Roh also contributes to educational excellence, guiding undergraduate and graduate students in research methodologies and scientific writing. Her blend of practical, clinical, and research experience strengthens her impact in both the cosmetic and biomedical sectors. She is known for her rigorous scientific approach and her drive to translate laboratory findings into real-world applications.

🏅 Awards and Honors:

Dr. Roh has received numerous accolades for her pioneering research in molecular pharmacology and cosmetic science. She was honored with the Outstanding Poster Presentation Award from the Korean Society of Microbiology and Biotechnology in June 2022, recognizing her innovative insights into skin-related biochemical mechanisms. Similarly, she earned the Outstanding Poster Presentation Award from the Korean Society of Cancer Prevention in November 2021 for her work on chemopreventive agents. Earlier, in 2019, she received the Summer Research Retreat Award (2nd place) from The Hormel Institute, University of Minnesota—an acknowledgment of her collaborative contributions to cancer biology. These awards underscore her reputation for research excellence, innovation, and dedication to advancing the fields of dermatology and cosmetology. Her consistent recognition at both national and international levels reflects her commitment to impactful science and her growing influence in molecular dermatology and cosmetic formulation research.

🔬 Research Focus:

Dr. Roh’s research primarily focuses on molecular and cellular targets involved in carcinogenesis, skin aging, and pigmentation. Her studies aim to understand the biochemical pathways influenced by solar UV radiation, and their role in inducing skin cancer and photoaging. She also explores mechanisms of melanogenesis, contributing to the discovery of anti-hyperpigmentation agents. A distinctive element of her work is the translation of pharmacological findings into cosmetic applications, bridging the gap between biochemistry and skincare innovation. Her recent work includes green tea polyphenols, sesame glycoproteins, and natural bioactives for UV protection. She also investigates novel formulations for transdermal drug delivery and anti-inflammatory responses in skin cells. Her holistic approach encompasses in vitro, in vivo, and 3D skin models, emphasizing both efficacy and safety. Her contributions are instrumental in developing scientifically validated cosmetics and preventive strategies against UV-induced damage and pigment disorders.

📚 Publications Top Notes:

  1. 🧴 Evaluation and analysis of major competency achievement in beauty and cosmetics students – J Korean Soc Cosmetol (2024)

  2. 🌿 Protective Effects of Sesame Glycoproteins on UV-Induced Skin Aging – Pharmaceuticals (2024)

  3. ☀️ Orobol suppresses development of cutaneous SCC – Biochem Pharmacol (2023)

  4. 💊 Topical Rocuronium Bromide Formulation for Skin Delivery – Int J Mol Sci (2023)

  5. 🧪 Higenamine reduces fine-dust-induced MMP-1 in keratinocytes – Plants (2023)

  6. 🔥 Targeting IKKβ in acetaminophen-induced hepatotoxicity – Pharmaceutics (2023)

  7. 🌸 Lotusine inhibits UV-induced MMP-1 – Plants (2022)

  8. 🔍 Structural basis of multifunctional roles of Ints3 C-terminal domain – J Biol Chem (2021)

  9. 🧬 GSK3β and WT1 in tumor progression – Cancer Res (2021)

  10. 🌞 Effectiveness of FDA-approved sunscreens against UV damage – Cells (2020)

🔚 Conclusion:

Dr. Eunmiri Roh is a highly qualified and outstanding researcher whose scientific contributions to dermatological pharmacology, cosmetic biochemistry, and skin health are both innovative and impactful. Her robust publication record, research awards, and international collaborations indicate that she is well-positioned to receive recognition such as the Best Researcher Award. With minor enhancements in grant leadership, mentorship roles, and translational outcomes, her academic profile could rise even further.

Gisela D’ANGELO | Cell Biology and Cancer | Best Researcher Award

Posted on by Cell Biologist

Dr. Gisela D’ANGELO | Cell Biology and Cancer | Best Researcher Award

Dr. Gisela D’ANGELO, CNRS, France

Dr. Gisela D’Angelo is a distinguished cell biologist and Research Director at CNRS, currently based at Institut Curie, Paris. Born in Montevideo, Uruguay (1961), she has built a notable career in molecular biology, specializing in the roles of extracellular vesicles (EVs) in cell communication, development, and disease. With over three decades of international experience and a profound academic foundation from top French institutions, she has contributed significantly to understanding vesicle-mediated signaling pathways. Her work has reshaped knowledge of cellular dynamics in development, virology, and cancer. She is affiliated with the UMR144 Cell Biology and Cancer Department, and her scientific leadership has guided impactful projects and collaborations across Europe. A mentor to several postdoctoral researchers, her prolific publication record and active role in translational research solidify her position as a leader in EV biology.

Publication Profile: 

Scopus

Orcid

✅ Strengths for the Award:

  1. World-Class Researcher in Extracellular Vesicles (EVs):
    Dr. D’Angelo has made pivotal contributions to understanding the biogenesis and function of extracellular vesicles in both developmental and pathological contexts, such as placental biology, viral infection, and cancer.

  2. Prolific Publication Record:
    She has authored and co-authored multiple high-impact journal articles in top-tier journals like PNAS, Nature Methods, Current Biology, and Development. Her publications are often collaborative and interdisciplinary, indicating a strong network in the global scientific community.

  3. Leadership Role and Institutional Prestige:
    Holding the title of Research Director (DR2 CNRS) at the Institut Curie—a premier research center in Europe—underscores her leadership and scientific excellence. She also mentors young scientists and leads innovative projects.

  4. Innovative Use of Imaging & Model Systems:
    Her work combines advanced microscopy, Drosophila genetics, and molecular biology to explore intercellular communication—offering novel insights with translational potential.

  5. International Profile and Experience:
    Originally from Uruguay, educated in Paris, and professionally established in France, Dr. D’Angelo reflects a truly international scientific career.

⚠️ Areas for Improvement:

  1. Teaching and Public Engagement:
    While she is involved in a Master-level course, increasing her visibility in teaching, mentoring, and public science outreach could enhance her broader scientific influence.

  2. Expanded Global Collaborations:
    Most of her research collaborations are within France or Europe. Developing larger-scale international consortia or initiatives could amplify her global impact.

  3. Science Communication and Media Presence:
    Her profile and findings could benefit from more exposure via science communication platforms, conferences, and open-access forums to reach broader audiences.

🎓 Education:

Dr. Gisela D’Angelo’s academic journey began at Université Pierre et Marie Curie (Paris VI), where she earned a BS in Cell Biology and Physiology (1984), followed by a Master’s degree in Reproductive Physiology (1986). She went on to complete her PhD in Molecular Biology and Reproductive Physiology in 1990 at the same university. Her research skills and academic rigor led her to pursue the Habilitation à Diriger des Recherches (HDR) in 2003 at Université de Nice Sophia-Antipolis, qualifying her to supervise doctoral research and lead independent scientific programs. Her education laid a strong interdisciplinary foundation, integrating molecular biology, cell physiology, and developmental biology—skills that she continues to apply in her research on intercellular communication and extracellular vesicles.

💼 Experience:

Dr. D’Angelo began her research career in France, first as a Research Associate at INSERM U615, University of Nice (2000–2005), followed by a role at CNRS UMR 7277/INSERM 1091 (2005–2017). She then joined Institut Curie, Paris, as a Senior Research Scientist (CRCN, CNRS), and was promoted to Research Director in 2024. Her extensive experience spans cellular communication, reproductive biology, and cancer research, with a focus on extracellular vesicles (EVs). She undertook a sabbatical at Institut Curie in 2016, which helped deepen collaborative efforts in vesicle biology. She is recognized for leading multidisciplinary teams, mentoring early-career scientists, and contributing to major breakthroughs in developmental biology, particularly through high-resolution imaging and molecular tools. With over 20 publications in top-tier journals, Dr. D’Angelo’s career reflects innovation, academic rigor, and impactful science.

🔬 Research Focus:

Dr. Gisela D’Angelo’s research revolves around the biogenesis, trafficking, and function of extracellular vesicles (EVs)—small, membrane-bound particles that mediate intercellular communication. Her work elucidates how EVs participate in developmental signaling pathways, immune regulation, placental communication, and disease pathogenesis (e.g., cancer, viral infections). A core part of her focus is understanding how microvilli-derived vesicles contribute to morphogenesis and tissue homeostasis, using advanced imaging and model organisms like Drosophila. She has also explored EV modifications by pathogens such as cytomegalovirus and their effects on fetal development. Her cutting-edge research combines molecular genetics, imaging technologies, and cell biology to dissect the subcellular mechanics of EV trafficking. As a leading figure in this dynamic field, she has significantly advanced understanding of how EVs act as messengers during physiological and pathological processes, making her work highly relevant to regenerative medicine, oncology, and developmental biology.

📚 Publications Top Notes:

  1. 🧪 Extracellular vesicles released by keratinocytes regulate melanosome maturation, melanocyte dendricity, and pigment transfer – PNAS, 2024

  2. 🤰 Placental extracellular vesicles in maternal-fetal communication during pregnancy – Biochemical Society Transactions, 2022

  3. 🦠 Human Cytomegalovirus modifies placental small extracellular vesicle composition to enhance infection of fetal neural cells in vitro – Viruses, 2022

  4. 🧬 Microvilli-derived extracellular vesicles carry Hedgehog morphogenic signals for Drosophila wing imaginal disc development – Current Biology, 2022

  5. 🔬 The power of imaging to understand extracellular vesicle biology in vivo – Nature Methods, 2021

  6. 🧫 Human Cytomegalovirus infection changes the pattern of surface markers of small extracellular vesicles – Frontiers in Cell and Developmental Biology, 2021

  7. 🧠 Centrosome amplification mediates small extracellular vesicle secretion via lysosome disruption – Current Biology, 2021

  8. 🧭 The GTPase Rab8 differentially controls Hedgehog gradient by regulating its apico-basal distribution – Development, 2021

  9. 🐛 Microvilli-derived extracellular vesicles govern morphogenesis in Drosophila wing epithelium – bioRxiv preprint, 2020

  10. 🧪 Centrosome amplification mediates EV secretion via lysosome disruption – bioRxiv preprint, 2020

  11. 🧩 The cell biology of extracellular vesicles: A jigsaw puzzle with a myriad of pieces – Review/Essay (unlisted journal)

🧾 Conclusion:

Dr. Gisela D’Angelo is highly suitable for the Best Researcher Award. Her exceptional contributions to extracellular vesicle research—combined with leadership, publication quality, and scientific impact—place her among the top scientists in her field. While she could enhance her visibility in teaching and international collaboration, her track record demonstrates consistent excellence, innovation, and commitment to advancing biomedical research. She represents the ideal profile of a senior investigator who bridges fundamental science and translational relevance.

Hongrui Meng | RNA biology | Best Researcher Award

Posted on by Cell Biologist

Dr. Hongrui Meng | RNA biology | Best Researcher Award

Dr. Hongrui Meng, Institute of Neuroscience, Soochow University, China

Dr. Hongrui Meng is a distinguished neuroscientist specializing in the molecular mechanisms underlying neurodegenerative diseases. With a Ph.D. in Behavioral Neuroscience from Hamamatsu University School of Medicine, Japan, Dr. Meng furthered his expertise through postdoctoral training at Juntendo University, Tokyo. He served as an assistant professor before establishing the Laboratory of Molecular Neurology at the Institute of Neuroscience, Soochow University, where he became a full professor in 2020. His pioneering work has made notable advances in understanding Parkinson’s disease, ALS, and mitochondrial dysfunction. Dr. Meng’s research integrates cellular, genetic, and biochemical tools using models ranging from Drosophila to mice. He has authored over a dozen peer-reviewed publications and holds international patents for novel molecular diagnostic techniques. Additionally, he collaborates with pharmaceutical companies to develop plant-based neuroprotective agents. As a committed mentor and leader, he contributes to scientific societies and editorial boards and is known for his translational approach in bridging basic science and therapeutic innovation.

Publication Profile: 

Scopus

Orcid

✅ Strengths for the Award:

  1. Pioneering Research in Neurodegeneration:
    Dr. Meng has significantly contributed to understanding the molecular and cellular mechanisms of neurodegenerative diseases, especially Parkinson’s disease and ALS, with a focus on mitochondrial dysfunction, protein aggregation, and innate immunity.

  2. International Academic Background and Collaborations:
    Educated and trained in Japan with active collaborations in both academic and industry sectors (e.g., Longma Pharmaceutical Co., Ltd.), Dr. Meng bridges global perspectives and translational goals effectively.

  3. Strong Publication and Patent Record:
    He has published over a dozen high-impact, peer-reviewed articles (SCI, Scopus indexed) and holds international patents in diagnostic methodology. His research output demonstrates consistency, innovation, and real-world applicability.

  4. Leadership in Research and Lab Management:
    As a full professor and founder of the Laboratory of Molecular Neurology at Soochow University, Dr. Meng leads a dynamic team with successful research grants, including from JSPS, NSFC, and Takeda Foundation.

  5. Interdisciplinary Focus:
    His work integrates behavioral neuroscience, molecular biology, genetics, and technology (e.g., wearable devices), illustrating a forward-looking and solution-oriented approach.

🛠️ Areas for Improvement:

  • Citation Impact (h-index):
    While his Scopus h-index (7) reflects a solid foundation, increased international visibility and broader citation engagement can elevate his standing among global peers.

  • Expanded Global Outreach:
    More international speaking engagements, global consortia leadership, and multi-center trials could further boost Dr. Meng’s influence and accelerate translation of his work.

🎓 Education:

Dr. Hongrui Meng earned his Ph.D. in Behavioral Neuroscience from Hamamatsu University School of Medicine, Japan. His doctoral research focused on neurobiological pathways implicated in behavioral disorders and neurodegenerative processes. Following this, he underwent rigorous postdoctoral training at Juntendo University in Tokyo, where he specialized in molecular neurobiology and human genetics. His interdisciplinary education and training provided him with a strong foundation in genetic, molecular, and cellular neuroscience, particularly as they relate to Parkinson’s disease and ALS. His academic journey was shaped by prestigious institutions known for cutting-edge neuroscience research and helped develop his expertise in mitochondrial dysfunction and protein aggregation mechanisms. Dr. Meng has continued to expand his knowledge through professional development and active engagement with academic societies in both China and Japan. His educational background has prepared him well to lead impactful, translational research in neurodegenerative disease therapy and drug discovery.

🧪 Experience:

Dr. Meng began his academic career in Japan, first as a doctoral researcher and later as a postdoctoral fellow focusing on molecular neurobiology and neurogenetics. He was appointed assistant professor in the Department of Research for Neurodegenerative Diseases and Dementia at Juntendo University. In 2020, he joined the Institute of Neuroscience at Soochow University as a full professor, where he established and currently leads the Laboratory of Molecular Neurology. Over his career, Dr. Meng has managed multiple international and national research projects supported by agencies such as the Japan Society for the Promotion of Science and the Natural Science Foundation of China. His projects span from fundamental mitochondrial research to applied wearable technologies for Parkinson’s monitoring. With over 12 years of research and academic leadership, he also provides consultancy to pharmaceutical companies and reviews for educational institutions. His international experience has made him a key contributor to the neurodegeneration research field.

🔬 Research Focus:

Dr. Meng’s research focuses on uncovering the cellular and molecular mechanisms of neurodegenerative diseases, particularly Parkinson’s disease and ALS. His lab investigates how mitochondrial dysfunction contributes to protein aggregation and neuronal death, with an emphasis on α-synuclein and CHCHD2-related pathways. Using transgenic Drosophila and rodent models, Dr. Meng’s work has identified key genetic mutations and stress response pathways, such as the mitochondrial unfolded protein response (mtUPR), that drive disease progression. His research also extends to glial cell biology, neuroinflammation, and the neuroimmune system’s role in maintaining neuronal integrity. Moreover, he is pioneering in drug discovery, developing plant-derived compounds and wearable technology for disease monitoring. His lab is currently involved in translational research, bridging basic molecular findings with therapeutic applications. Dr. Meng’s studies are multidisciplinary, combining genetics, molecular biology, imaging, and behavioral neuroscience, aiming to transform discoveries into real-world interventions for neurodegenerative conditions.

📚 Publications Top Notes:

  1. 🧬 Dicer Is Involved in Cytotoxicity and Motor Impairment Induced by TBPH Deficiency – Current Issues in Molecular Biology, 2025

  2. 🧠 Alpha-Synucleinopathy Disrupts Microglial Homeostasis in Parkinson’s Disease – Cell Communication and Signaling, 2024

  3. 🧪 Transcriptomic Analysis of Lipid Metabolism Genes in Alzheimer’s Disease – Journal of Molecular Neuroscience, 2024

  4. 🔬 CHCHD2 Mutation Alters Ca2+ Homeostasis in ALS – PNAS Nexus, 2024

  5. 🧫 A Simple Technique to Assay Locomotor Activity in Drosophila – Journal of Visualized Experiments, 2023

  6. 🧍‍♂️ MHCI Deficiency Induces ADHD-like Symptoms – Brain Behavior and Immunity, 2021

  7. 🧠 Twin CHCH Proteins in Parkinson’s and ALS – International Journal of Molecular Sciences, 2019

  8. 🧪 CHCHD2 Mutations Cause Alpha-Synuclein Aggregation – Human Molecular Genetics, 2019

  9. 🧬 Monitoring Mitochondrial Changes via Pink1-Parkin Signaling in Drosophila – Methods in Molecular Biology, 2018

  10. 🧪 Loss of CHCHD2 Affects Mitochondrial Cristae and Cytochrome C – Nature Communications, 20

🧾 Conclusion:

Dr. Hongrui Meng exemplifies the qualities of a top-tier neuroscientist: innovation, academic rigor, leadership, and translational vision. His multidisciplinary work contributes directly to unmet clinical needs in Parkinson’s and ALS, backed by strong research funding, publications, and patent activities.

Raphael Borie | Gene Regulation Epigenetics | Best Researcher Award

Posted on by Cell Biologist

Prof. Dr. Raphael Borie | Gene Regulation Epigenetics | Best Researcher Award

Prof. Dr. Raphael Borie, APHP, France

Dr. Raphaël Borie, born on August 15, 1977, in Paris, France, is a leading expert in pulmonology and genetic respiratory diseases. Currently a University Professor Hospital Practitioner at Bichat Hospital (Paris Cité University), he has consistently contributed to the advancement of respiratory medicine, particularly in the field of interstitial lung diseases (ILDs). His clinical insight, combined with a strong research portfolio, has positioned him as a prominent figure within the OrphaLung network. A dedicated family man with two children, Dr. Borie is widely respected for his integrity, leadership, and commitment to collaborative medicine. His career reflects a unique blend of academic excellence and impactful translational research, bridging the gap between genomics and clinical care in ILD. He is a registered member of the French Medical Council (Ordre des Médecins No. 75/71138), and his research has influenced European clinical guidelines and improved the understanding of rare genetic pulmonary conditions.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Robust Academic Background:
    Dr. Borie holds a PhD in Genetics, Master’s in Physiology, and HDR (habilitation to supervise doctoral research), which underlines his scientific credibility and ability to lead independent research.

  2. Clinical-Research Integration:
    As a University Professor and Hospital Practitioner, he merges frontline patient care with cutting-edge genetic and respiratory disease research.

  3. High Publication Impact:
    With 283 PubMed-indexed articles and an H-index of 60, Dr. Borie’s work demonstrates strong citation influence, indicating widespread recognition and utility in the scientific community.

  4. International Leadership:
    Active in multinational collaborations (e.g., OrphaLung, ERS), he has co-authored major position statements and clinical trials, influencing European respiratory care guidelines.

  5. Innovation in Rare Diseases:
    A recognized expert in familial interstitial lung disease and telomere disorders, his work has led to earlier diagnosis and targeted therapies—critical in fields where few experts exist.

  6. Recognition and Funding:
    He has secured prestigious mobility grants (ERS, Respirology Teachers College)—a marker of trust in his scientific mission and innovation.

🔍 Areas for Improvement:

  • Wider Public Health Translation: While Dr. Borie’s genomic research is exceptional, expanding into real-world health policy implementation could enhance systemic impact.

  • Patient Engagement & Advocacy: Developing patient-oriented tools or registries (e.g., digital apps or platforms for familial lung diseases) may broaden his outreach beyond academia and clinics.

  • Broader Visibility: Although highly cited in professional circles, participation in international keynote talks, editorial leadership, or mainstream health media could elevate his public and professional visibility.

🎓 Education:

Dr. Borie has pursued an extensive and rigorous academic path focused on respiratory and genetic medicine. He obtained his medical degree with specialization in Allergology and Immunopathology in 2006. A year earlier, in 2005, he earned a Master’s degree in Biology and Physiology of Circulation and Respiration. Demonstrating deep interest in genetics, he completed a PhD in Genetics in 2017, contributing significantly to our understanding of genetic underpinnings in pulmonary fibrosis. In 2019, Dr. Borie achieved the prestigious Habilitation à Diriger des Recherches (HDR) from the University of Paris 7, enabling him to supervise doctoral research. His academic background illustrates a powerful integration of clinical expertise and molecular research—providing him with the tools to lead innovative research projects at the intersection of genomics and pulmonology.

🩺 Experience:

Dr. Raphaël Borie has over 15 years of experience in respiratory medicine. From July 2011 to August 2020, he served as a Hospital Practitioner in the Pneumology Department at Bichat Hospital under Professors Aubier and Crestani. Since September 2020, he has been a University Professor Hospital Practitioner in the same department, affiliated with Paris Cité University. He has contributed to patient care, education of medical students and residents, and cutting-edge research. As part of the OrphaLung network, he plays a critical role in advancing diagnostic tools and treatment approaches for rare lung diseases. He is recognized for his collaborative leadership and interdisciplinary contributions across genetics, immunology, and pulmonology. His international collaborations and authorship of over 280 PubMed-indexed publications demonstrate his ongoing commitment to improving patient outcomes through translational research.

🏆 Awards and Honors:

Dr. Borie’s research excellence has been recognized through several prestigious awards and scholarships. In 2017, he received the European Respiratory Society (ERS) Mobility Grant for his work on Identification of Preclinical Markers of Pulmonary Fibrosis, supporting international collaboration and advanced training. The same year, he was also honored with the Respirology Teachers College Mobility Grant, reinforcing his pioneering research on early detection of fibrotic lung disease. His selection for these awards highlights both scientific innovation and dedication to knowledge exchange. His leadership in multi-center studies and involvement in ERS guideline statements further reflect his status as a thought leader in interstitial lung disease. These honors are a testament to his influence in shaping the future of pulmonary genetics and translational respiratory medicine.

🔬 Research Focus:

Dr. Raphaël Borie’s research centers on familial and genetic interstitial lung diseases, particularly the molecular mechanisms behind pulmonary fibrosis, telomere biology, surfactant-related gene variants, and early detection strategies. He works extensively on identifying genetic risk variants (e.g., MUC5B, DSP) and their implications in idiopathic pulmonary fibrosis. Through his participation in the OrphaLung network, he supports genomic screening for hereditary lung disorders and contributes to developing European guidelines. His work bridges genomic medicine and clinical pulmonology, aiming for earlier diagnosis and personalized treatment approaches. He has led and co-authored critical studies on RTEL1 mutations, telomerase complex defects, and familial ILD phenotypes, helping clinicians globally understand the heterogeneity and systemic implications of genetic lung disorders. His collaborative international research ensures his findings are applied in practice to optimize long-term patient care.

📚Publications Top Notes:

  • 🧬 High risk of lung cancer in surfactant-related gene variant carriers – Eur Respir J, 2024

  • 📄 European Respiratory Society Statement on Familial Pulmonary Fibrosis – Eur Respir J, 2022

  • 🧪 Colocalization of Gene Expression and DNA Methylation with Genetic Risk Variants – Am J Respir Crit Care Med, 2022

  • 🧬 RTEL1 mutations and their phenotypic variability – Eur Respir J, 2019

  • 💊 Safety and efficacy of pirfenidone in telomerase mutation carriers – Eur Respir J, 2018

  • 🌐 Diagnosis and follow-up of familial ILD: International survey – BMC Pulmonary Med, 2025

  • 🧬 New 2023 ACR/EULAR APS criteria performance in young patients – Letter, 2025

  • 🫁 A non-resolving cough: a case of familial pulmonary fibrosis – Breathe, 2025

  • 🧬 PFMG2025: Genomic medicine in French healthcare system – Review, 2025

  • 💊 Efficacy of CFTR modulators in ABCA3-deficiency ILD – Open Access, 2025

  • 🧠 Neurological manifestations in VEXAS syndrome – Journal of Neurology, 2025

  • 💉 Real-life use of PEXIVAS reduced-dose regimen in vasculitis – Ann Rheum Dis, 2025

  • 🧫 Recurrent respiratory papillomatosis with lung involvement – Eur Respir J, 2025

  • 🔍 RA-ILD: genetics to clinical overview – Review, 2025

  • 👶 Childhood ILD survivors in adulthood: European study – Eur Respir J, 2025

🧾 Conclusion:

Dr. Raphaël Borie exemplifies the ideal candidate for the Best Researcher Award. His excellence spans across clinical expertise, academic distinction, and international research leadership, especially in genetic and familial interstitial lung diseases—a field with enormous unmet need. His consistent scholarly output, impactful collaborations, and patient-focused studies highlight a unique blend of depth and innovation. While further expansion into public health frameworks and patient engagement tools would be valuable, his profile already reflects a world-class researcher with transformative contributions to pulmonary medicine.

Alla Mitrofanova | Lipid Signaling Biology | Best Researcher Award

Posted on by Cell Biologist

Dr. Alla Mitrofanova | Lipid Signaling Biology | Best Researcher Award

Dr. Alla Mitrofanova | University of Miami | United States

Dr. Alla Mitrofanova is a Research Assistant Professor at the University of Miami Miller School of Medicine, specializing in the molecular and cellular mechanisms underlying kidney diseases. Holding dual citizenship in the United States and Russia, she has a robust international academic background and a solid reputation in nephrology research. Dr. Mitrofanova has significantly contributed to understanding podocyte biology and renal lipid metabolism. With a Ph.D. in Human Physiology and postdoctoral training in Molecular Biology, she has collaborated with leading scientists in the field and is a co-author of high-impact publications. Her academic journey reflects a blend of rigorous scientific training, innovation, and commitment to mentorship. A recognized member of various research consortia, she brings both clinical relevance and basic science rigor to her work, particularly in diabetic kidney disease and transplant nephrology. Her efforts position her as a strong candidate for the Best Researcher Award.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. 🔬 High-Impact Research Focus:

    • Strong emphasis on podocyte biology, diabetic kidney disease, and glomerular disorders, which are critical areas in nephrology research.

    • Research addresses fundamental disease mechanisms (lipid dysmetabolism, ER stress, pyroptosis), showing translational potential for therapy.

  2. 📚 Prolific and High-Quality Publications:

    • Authored/co-authored 10+ peer-reviewed articles in top-tier journals like Nature Reviews Nephrology, Kidney International, eLife, and Frontiers in Immunology.

    • Publications include commentaries, reviews, and original research, showcasing versatility.

  3. 🤝 Interdisciplinary and Collaborative Approach:

    • Works closely with globally recognized scientists such as Dr. Alessia Fornoni and Dr. George Burke.

    • Participates in cross-functional teams that bridge molecular science with clinical nephrology.

  4. 📈 Career Progression & Mentorship:

    • Rapid academic progression from Research Instructor to Research Assistant Professor.

    • Member of formal mentoring committees and contributes to the development of junior researchers.

  5. 📖 Author of Book Chapter:

    • Co-authored a chapter in Current Progress in Nephrology, reinforcing subject matter expertise.

🔄 Areas for Improvement:

  1. 💼 Independent Funding Leadership:

    • While research involvement is significant, leading grants as Principal Investigator (PI) would strengthen her portfolio and independence.

  2. 🌍 International Visibility:

    • Encouraged to expand international presence through invited lectures, keynote talks, and scientific panels.

  3. 🧭 Broader Research Footprint:

    • Future work could benefit from involvement in large-scale clinical trials, or application of findings to diverse patient populations.

  4. 🧪 Innovation in Techniques:

    • Introduction of new methods (e.g., single-cell omics, AI-driven histopathology) could further enhance impact.

📘 Education:

Dr. Mitrofanova completed her undergraduate degree in Biology (B.S., 2006) and a Master’s in Human Physiology (M.S., 2008) at Saint Petersburg State University, Russia. She earned her Ph.D. in Human Physiology in 2011 from the same institution, where she focused on cellular stress responses. To expand her expertise, she pursued postdoctoral training at the prestigious Schemyakin and Ovchinnikov Institute of Bioorganic Chemistry, focusing on Molecular Biology (2011–2013). This education provided her with interdisciplinary expertise spanning physiology, molecular biology, and disease pathophysiology. Her academic training integrates European rigor with international research exposure, laying a strong foundation for her scientific pursuits. Throughout her education, Dr. Mitrofanova has demonstrated excellence in both experimental design and translational relevance, which she continues to leverage in her current roles in the U.S.

🧪 Experience:

Dr. Mitrofanova currently serves as a Research Assistant Professor in the Department of Medicine at the University of Miami Miller School of Medicine. Since 2020, she has progressively advanced from a Research Instructor to her current rank, where she leads and contributes to multidisciplinary projects in nephrology. Her career began in academia and research institutions in Russia before transitioning to the U.S. She has worked closely with world-renowned mentors including Dr. Alessia Fornoni and Dr. George Burke. Her research has garnered substantial peer-reviewed publications, and she actively contributes to translational nephrology through collaborative and independent studies. Additionally, she plays a role in mentoring early-career researchers. Her deep involvement in both experimental and clinical nephrology research makes her a valuable asset to her department and a credible candidate for recognition in the scientific community.

🔬 Research Focus:

Dr. Mitrofanova’s research centers on the molecular mechanisms of chronic kidney diseases, particularly diabetic nephropathy and glomerular diseases. A primary area of focus is podocyte biology, including the roles of lipid metabolism, endoplasmic reticulum stress, and immune regulation in kidney pathology. Her work on SMPDL3b, ABCA1, and oxysterol-binding proteins has shed light on key pathways linking lipid dysregulation to proteinuria and CKD progression. She is also engaged in transplant nephrology, using transplantation models to study disease recurrence. Dr. Mitrofanova has been instrumental in decoupling proteinuria from CKD progression and identifying biomarkers and therapeutic targets. Her research bridges basic science with clinical application, aiming to identify precision therapies for kidney disease patients. The integration of advanced molecular biology tools and translational approaches highlights the innovative and impactful nature of her work in nephrology.

📚 Publications Top Notes:

  1. 🧬 SMPDL3b in Podocytes: Decoupling Proteinuria from CKD Progression in Experimental Alport Syndrome – Kidney International, 2025

  2. 🔬 Oxysterol-binding protein like 7 deficiency leads to ER stress-mediated apoptosis in podocytes and proteinuria – AJP Renal, 2024

  3. 🧠 Role of immune podocyte in glomerular diseases – Cells, 2024

  4. 🧫 Transplantation: platform to study recurrence of disease – Frontiers in Immunology, 2024

  5. 💡 The finer points of podocyte sphingolipid metabolism in diabetic kidney disease – Scientific Archives, 2023

  6. 💊 Management of Lupus Nephritis: New Treatment and Updated Guidelines – Kidney360, 2023

  7. 🔄 Renal lipid dysmetabolism in chronic kidney disease – Nature Reviews Nephrology, 2023

  8. 🧪 The podocyte: glomerular sentinel at the crossroads of innate and adaptive immunity – Frontiers in Immunology, 2023

  9. ⚙️ ABCA1 deficiency contributes to podocyte pyroptosis priming via APE1/IRF1 axis – Scientific Reports, 2023

  10. 🌿 Empagliflozin reduces renal lipotoxicity in experimental Alport syndrome – eLife, 2023

📝 Conclusion:

Dr. Alla Mitrofanova exhibits outstanding scientific productivity, depth in nephrology research, and a strong academic trajectory. Her contributions have significantly advanced our understanding of podocyte pathophysiology and kidney disease mechanisms. With continued focus on independent leadership and global engagement, she has the potential to emerge as a key innovator in the field.

Naoki Harada | Molecular Mechanisms Signaling | Best Researcher Award

Posted on by Cell Biologist

Dr. Naoki Harada | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Naoki Harada, Osaka Metropolitan University, Japan

Naoki Harada is an Associate Professor at Osaka Metropolitan University, Japan, with extensive expertise in molecular biology, biochemistry, endocrinology, and nutrition. He earned his Ph.D. in Life Sciences from Osaka Prefecture University in 2007. Over the past two decades, Harada has made significant contributions to understanding the physiological and biochemical mechanisms underpinning metabolic diseases, particularly type 2 diabetes. His research, characterized by high citation impact (H-index of 25), centers on pancreatic β-cell function and metabolic regulation. He has published 77 peer-reviewed articles and holds a patent related to therapeutic interventions. Harada has collaborated with leading scientists like Professors Hiroshi Inui and Ryoichi Yamaji, strengthening his academic footprint in both national and international circles. A member of multiple scientific societies, Harada continues to influence the field through impactful research, industry collaboration, and educational leadership.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Consistent Research Output

    • 77 peer-reviewed publications in reputable journals (SCI, Scopus).

    • Recent high-impact studies published in Journal of Biological Chemistry, Scientific Reports, and FASEB BioAdvances.

    • Active research profile with an H-index of 25 and over 1,785 citations.

  2. Innovative Scientific Contributions

    • Identified REDD2 as a novel therapeutic target for type 2 diabetes—bridging basic research with translational medicine.

    • Works across disciplines such as molecular biology, endocrinology, and nutritional biochemistry.

  3. Project Leadership & Industry Engagement

    • Led or participated in 14 major research projects.

    • 5 consultancy/industry-based projects, reflecting application-oriented research.

  4. Academic and Collaborative Network

    • Strong academic collaborations with Professors Hiroshi Inui and Ryoichi Yamaji.

    • Member of prestigious scientific societies (e.g., Japanese Biochemical Society, Japan Society of Nutrition and Food Science).

  5. Scientific Versatility

    • Contributions span fundamental mechanisms (e.g., oxidative stress, insulin signaling) to dietary interventions (e.g., mogrol, oleamide).

    • Demonstrates ability to bridge molecular insights with systemic physiological outcomes.

⚙️ Areas for Improvement:

  1. International Visibility and Engagement

    • Expanding participation in international conferences and editorial boards could elevate his global scientific standing.

    • Pursuing cross-border collaborations would further enrich the translational value of his work.

  2. Commercialization and Patent Activity

    • While one patent is noted, increased focus on intellectual property development and biomedical commercialization could further validate his applied research strength.

  3. Outreach and Communication

    • More active public science communication (e.g., webinars, policy advocacy, media coverage) would amplify the societal impact of his research.

🎓 Education:

Naoki Harada received his Ph.D. in Life Sciences from Osaka Prefecture University, Osaka, Japan, in September 2007. His doctoral studies laid the foundation for his interdisciplinary research in molecular biology, biochemistry, and endocrinology. Harada’s academic path was driven by a keen interest in the cellular and molecular mechanisms underlying metabolic regulation, particularly in relation to glucose homeostasis and pancreatic function. His education provided him with a solid grounding in experimental techniques, critical thinking, and scientific communication, which have become hallmarks of his later work. The institution, known for excellence in biosciences, enabled Harada to cultivate a strong research acumen. His academic training was complemented by exposure to applied research, linking basic science with clinical and nutritional applications—an approach that he has continued to emphasize throughout his career. His strong educational background plays a pivotal role in his current research endeavors and professional development.

💼 Experience:

Dr. Naoki Harada began his academic career in 2008 as an Assistant Professor at the Graduate School of Life and Environmental Sciences, Osaka Prefecture University. He was promoted to Lecturer in 2015, and subsequently to Associate Professor in 2019. Since 2022, he has served as Associate Professor at the Graduate School of Agriculture, Osaka Metropolitan University. Harada has consistently combined teaching with intensive research, mentoring graduate students while advancing his lab’s focus on metabolic diseases and endocrine physiology. His experience includes leading 14 research projects, consulting on 5 industry-linked nutrition initiatives, and co-authoring over 75 scientific papers. His experience reflects a blend of academic leadership, scientific innovation, and multidisciplinary collaboration. Notably, Harada’s role in identifying REDD2 as a therapeutic target exemplifies his contribution to translational science. He maintains strong academic partnerships and actively contributes to several professional societies, making him a respected figure in Japan’s scientific community.

🔬 Research Focus:

Naoki Harada’s research is at the intersection of molecular biology, endocrinology, and nutrition science, with a particular focus on pancreatic β-cell physiology and glucose metabolism. He investigates how oxidative stress, hormonal signals, and metabolic regulators influence insulin secretion and β-cell viability. One of his pivotal contributions is identifying the REDD2 gene as a negative regulator of β-cell function, offering novel therapeutic targets for type 2 diabetes mellitus. His studies also explore nutrient-sensing pathways, G-protein-coupled receptors, and hormonal modulation of energy metabolism. Harada’s recent work delves into the effects of dietary compounds like mogrol and oleamide on metabolic health, linking molecular mechanisms to real-world dietary interventions. His ability to bridge bench science with clinical and nutritional applications sets his research apart. Through collaborations with leading experts and high-impact publications, Harada continues to advance knowledge in the prevention and treatment of metabolic disorders.

📚 Publications Top Notes:

  • 🧬 REDD2 confers pancreatic β-cell dysfunction in high-fat diet-fed mice – Journal of Biological Chemistry, 2025

  • 🦷 Androgens suppress ST3GAL1/4, modulating mucin glycosylation and microbiota in mice – Bioscience, Biotechnology, and Biochemistry, 2025

  • 🍟 CRTC1 in MC4R cells regulates dietary fat intake – FASEB BioAdvances, 2024

  • 💉 Insulin reduces ER stress-induced apoptosis in INS-1 β-cells – Physiological Reports, 2024

  • 🍬 Mogrol activates GPBAR1 and insulin secretion, alleviates hyperglycemia – Scientific Reports, 2024

  • 🔥 Androgen receptor suppresses β-adrenoceptor-mediated thermogenesis – Journal of Biological Chemistry, 2022

  • 🏥 Age-dependent sex differences in NAFLD in TSOD and db/db mice – PLOS ONE, 2022

  • 🐭 Dietary oleamide attenuates obesity in caged mice – Bioscience, Biotechnology, and Biochemistry, 2022

  • 🌿 Curcumin targets GPR55 receptor – npj Science of Food, 2022

  • 💪 Oleamide rescues muscle atrophy in small-caged mice – British Journal of Nutrition, 2021

🧾 Conclusion:

Dr. Naoki Harada demonstrates a clear trajectory of research excellence, grounded in scientific rigor and driven by impactful biomedical questions. His ability to identify molecular mechanisms (e.g., REDD2’s role in β-cell dysfunction) and propose therapeutic directions sets him apart as a leading academic in metabolic disease research. His publication record, industry collaborations, and professional memberships underscore a mature and influential academic career.

Madeha Awad | Intracellular Transport Systems | Best Researcher Award

Posted on by Cell Biologist

Assoc. Prof. Dr. Madeha Awad | Intracellular Transport Systems | Best Researcher Award

Assoc. Prof. Dr. Madeha Awad, Sohag university, Egypt

Dr. Madeha Ahmed Aboelfadl Awad is an accomplished Associate Professor in the Physics Department, Faculty of Science, Sohag University, Egypt. Born on January 27, 1979, she has established herself as a leading researcher in the field of nanomaterials physics, with a focus on the synthesis and characterization of metal, metal oxide, and oxysulfide nanostructures. Fluent in Arabic, English, and French, Dr. Awad has contributed extensively to sustainable material applications, including photocatalysis, photodetectors, and smart coatings. Her passion for scientific inquiry and dedication to environmental and energy-related innovations have positioned her as a significant academic voice in Egypt and internationally. Married and residing in Sohag, she continues to inspire through both her teaching and prolific research publications, contributing to over 10 international journal articles and conference presentations. Dr. Awad’s interdisciplinary approach bridges materials science with real-world industrial and environmental applications.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Innovative Research Focus:
    Dr. Awad has demonstrated consistent innovation in synthesizing and characterizing advanced nanostructured systems (metal oxides, oxysulfides, and thin films), with real-world applications in environmental remediation, energy conversion, and optoelectronics.

  2. Publication Record:
    She has published 10+ articles in reputable international journals such as Physica Scripta and Journal of Materials Science: Materials in Electronics. Many of these works address pressing global challenges, including pollution control, clean energy, and smart coatings.

  3. Multidisciplinary Impact:
    Her work intersects physics, materials science, and environmental engineering, creating sustainable technologies like photocatalysts, hydrogen generation systems, and photodetectors.

  4. Active Conference Participation:
    Dr. Awad has presented at national and international scientific conferences, sharing her findings on SnO₂ thin films and transparent conductors, reflecting leadership in academic dissemination.

  5. Academic Development:
    She has completed multiple training courses in competitive research, digital transformation, and teaching methodologies, ensuring continuous growth and contribution to higher education quality.

🧩 Areas for Improvement:

  1. International Collaborations:
    While Dr. Awad is actively publishing, there is potential for expanding collaborations with global research institutes and industrial sectors to enhance the scope and visibility of her work.

  2. Research Funding Diversification:
    Engaging in international grant applications or large-scale collaborative projects would further strengthen her research sustainability and resource access.

  3. Visibility in High-Impact Conferences:
    Increasing participation in high-impact global conferences or symposiums (e.g., MRS, APS) could amplify her academic footprint and foster more research exchange.

🎓 Education:

Dr. Awad earned her B.Sc. in Physics with a very good degree from Sohag University in 2003. She pursued her M.Sc. in Solid State Physics (2008), focusing on the structural, electrical, and optical properties of Sn-Sb-Se compounds. In 2015, she received her Ph.D. in Nanomaterials Physics for her pioneering work on ZnO-based nanomaterials. Her Ph.D. research emphasized growth and characterization techniques vital for optoelectronic applications. In October 2020, she became an Associate Professor, having specialized in the synthesis and analysis of nanostructured systems, including metal oxides and oxysulfides, with targeted industrial uses. Her academic path reflects a deep commitment to solid-state physics, materials engineering, and nanotechnology. She has also enhanced her academic competencies with digital transformation, student assessment, and competitive research training, aligning her education with modern interdisciplinary needs and research innovations.

🧪 Professional Experience:

Dr. Awad began her academic journey as an Assistant Lecturer in 2013 at Sohag University’s Physics Department. Following the completion of her Ph.D. in 2015, she was promoted to Lecturer, contributing to undergraduate and postgraduate instruction while intensifying her research. In 2020, she was appointed Associate Professor in Materials Science. Over the years, Dr. Awad has participated in international conferences, served as a research mentor, and collaborated with national and international scholars. Her expertise in synthesizing thin films and evaluating their optical, structural, and electrical characteristics has enabled her to lead multiple applied research projects. In addition to teaching and supervision, she has completed various training programs on student assessment, digital transformation, and competitive research funding. Her holistic academic profile blends high-impact research with educational excellence, making her a valuable contributor to Egypt’s scientific and academic landscape.

🔬 Research Focus:

Dr. Madeha Awad’s research focuses on the synthesis, characterization, and application of nanostructured materials, particularly metal and metal oxide thin films. Her work addresses real-world challenges through environmentally friendly solutions such as photocatalysis for pollutant degradation, hydrogen generation from seawater, and smart coatings for self-cleaning surfaces. She is also active in developing photodetectors for environmental sensing. Her interdisciplinary approach integrates solid-state physics, material science, and environmental engineering. Her recent projects involve advanced nanocomposites like In2O3/CuO and TiO2-based systems, with optimized optoelectronic and wettability properties for diverse industrial applications. By modifying surface and structural properties of nano-films, Dr. Awad aims to enhance energy efficiency, sustainability, and environmental remediation technologies. She is a strong advocate for applied research and often collaborates on global research initiatives that promote clean energy and green technologies. Her vision merges innovation with impact.

📚 Publications Top Notes:

  1. 🔬 Photocatalytic characteristics of indium oxide, copper oxide and indium oxide/copper oxide thin films on plastic waste substrates for organic pollutants degradation

  2. 🔍 Influence of oxygen flow rates on the optoelectronic properties SnO2 thin films

  3. 🌿 A comparison between the effect of zinc oxide and zinc oxide nanoparticles on the growth and metabolic processes of Cosmarium sp

  4. 🌞 Highly sensitive TiO2 based photodetector for environmental sensing applications

  5. 🔦 Optoelectronic characteristics of In2O3/CuO thin films for enhanced visible-light photodetector

  6. 🧼 Photocatalysis, wettability and optical properties of N-doped Cu2O/CuO thin films for smart coating applications

  7. 💧 Surface wettability and photocatalytic activities of ZrOxNy/Au/TeO2 trilayers for antifogging coatings

  8. ⚡ Some characteristics of Cu/Cu2O/CuO nanostructure heterojunctions and their applications in hydrogen generation from seawater

  9. 🌐 WNxOy prepared by oxidation of tungsten nitride as alternative photocatalyst to N-doped WO3

📝 Conclusion:

Dr. Madeha Ahmed Aboelfadl Awad exemplifies the qualities of a modern researcher who blends academic rigor with real-world impact. Her research in nanomaterials for environmental and energy applications is both timely and significant. With a strong foundation in materials science and a clear trajectory of impactful publications, she is an excellent candidate for the Best Researcher Award.

Prity Yadav | Cell Death Pathway | Best Researcher Award

Posted on by Cell Biologist

Ms. Prity Yadav | Cell Death Pathway | Best Researcher Award

Ms. Prity Yadav, UNIVERSITY OF RAJASTHAN, JAIPUR, India

Prity Yadav is a dedicated research scholar at the Department of Zoology, University of Rajasthan, Jaipur, India. Under the guidance of Prof. P.C. Mali, she is pursuing a PhD focused on nanotechnology and reproductive biomedicine. With a strong academic foundation including an M.Sc. in Zoology and CSIR-NET-JRF qualification, she currently receives the Senior Research Fellowship (SRF) from CSIR, Delhi. Her interdisciplinary research combines herbal medicine and nanoscience to develop eco-friendly contraceptive strategies, aiming to revolutionize non-hormonal fertility control. Prity has published 11 research papers in reputed journals indexed in SCI and Scopus, and actively contributes to the scientific community through her work. A member of the Indian Science Congress Association, she is passionate about public health, sustainability, and the responsible use of nanobiotechnology for population control and reproductive health. Her work holds significant promise for advancing global reproductive healthcare through innovative, natural, and non-invasive solutions.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Focused and Impactful Research Area
    Prity Yadav’s interdisciplinary research on nanotechnology and reproductive biomedicine is both relevant and innovative, especially in addressing global concerns like non-hormonal contraception, male fertility regulation, and eco-friendly biomedical alternatives.

  2. Consistent Publication Record
    With 11 publications in reputed SCI and Scopus-indexed journals, her research contributions are well-documented and consistently recognized in the academic community.

  3. Research Innovation
    Her work in green synthesis of silver nanoparticles using medicinal plant extracts for antifertility treatments reflects high originality and societal relevance.

  4. Academic Excellence
    She has cleared CSIR-NET-JRF and is currently receiving SRF from CSIR, showing national-level academic competitiveness.

  5. Sustainability and Public Health Focus
    Her projects promote natural, sustainable alternatives to conventional fertility control methods, aligning with public health policy and eco-conscious innovation.

  6. Active Membership in Scientific Community
    Her involvement in organizations such as The Indian Science Congress Association supports her engagement in broader scientific discourse.

🔧 Areas for Improvement:

  1. International Collaborations & Exposure
    Participation in international research collaborations, conferences, or exchange programs would further enrich her global perspective and strengthen her research profile.

  2. Patent Filing and Intellectual Property
    Considering the novelty of her nanoformulations, pursuing patents could enhance the impact and translational value of her work.

  3. Industry Engagement
    Involvement in consultancy or industry-based projects would bridge the gap between lab research and real-world application.

  4. Editorial and Peer Review Roles
    Taking on editorial responsibilities or peer-review contributions would boost her academic service profile.

🎓 Education:

Prity Yadav has a solid academic background in life sciences, specializing in Zoology. She completed her Master of Science (M.Sc.) in Zoology with distinction, focusing on reproductive physiology and applied biology. Demonstrating her academic excellence, she cleared the highly competitive CSIR-NET-JRF examination, qualifying for Junior Research Fellowship and later advancing to Senior Research Fellowship (SRF) funded by CSIR, New Delhi. She is currently enrolled in the PhD program at the University of Rajasthan, Jaipur, under the supervision of Prof. P.C. Mali in the Department of Zoology. Her academic path reflects a consistent focus on animal biology, toxicology, and molecular studies related to fertility and reproduction. Her strong theoretical knowledge, combined with hands-on laboratory training in nanoscience and biomedical research, sets a solid foundation for her innovative research. Prity’s education is a blend of traditional life sciences and modern interdisciplinary tools like nanotechnology and phytomedicine.

🧪 Experience:

Prity Yadav has accumulated significant research experience during her doctoral studies at the University of Rajasthan. With over four years of hands-on laboratory work, she has become proficient in nanoparticle synthesis, in vivo animal experimentation, biochemical analysis, and histopathological techniques. Her research focuses on developing green-synthesized silver nanoparticles using herbal extracts and evaluating their antifertility effects in male rodents. She has co-authored 11 publications in reputable journals and collaborated with fellow researchers on interdisciplinary projects involving herbal pharmacology, nanomedicine, and reproductive biology. While she has no direct industry consultancy experience, her academic research aligns closely with pharmaceutical applications. She frequently presents her findings in national and international conferences and is an active member of the Indian Science Congress Association. Prity’s experience highlights her commitment to scientific rigor, ethical research practices, and a vision for creating sustainable healthcare solutions through biocompatible nanotechnologies.

🔬 Research Focus:

Prity Yadav’s research lies at the intersection of nanotechnology and reproductive biomedicine, with an emphasis on developing herbal-based, non-hormonal antifertility agents. Her work explores the green synthesis of silver nanoparticles using medicinal plant extracts, aiming to enhance bioavailability and targeted delivery of active phytoconstituents. The ultimate goal of her research is to create eco-friendly, reversible male contraceptive methods with minimal side effects. She focuses on evaluating the impact of these nanoparticles on male reproductive systems through in vivo studies using rodent models. Her findings contribute to a deeper understanding of reproductive toxicity, oxidative stress, and fertility regulation mechanisms. This research addresses global challenges such as overpopulation and limited access to safe male contraceptives. Prity’s interdisciplinary approach supports sustainable healthcare by integrating traditional herbal knowledge with modern nanoscience, opening new avenues in contraceptive technology and public health policy.

📚 Publications Top Notes: 

  1. 🌿🔬 Herbal Nanoparticles to Control Fertility and Regulation: A Review

  2. 🧫🔥 Testicular Inflammation in Male Reproductive System

  3. 🍃🧪 Assessment of the Antifertility Potential of Silver Nanoparticles Synthesized Using Pongamia pinnata Leaf Extract in Male Wistar Rats

  4. 🌱📖 Medicinal Plants Potentials of Fertility Control, Antioxidant and Antimicrobial Activities: A Review

  5. 🧬🌿 Potential Antifertility and Antimicrobial Activities of Plants Used in Traditional Medicines: A Review

  6. 💊🦠 Cassia auriculata-Based Silver Nanoparticles: A Novel Approach to Combat Bacterial Infections

  7. 🌾🧠 A Review on Potential Antioxidant, Neuroprotective and Antidepressant Activities of Herbal Medicinal Plants

  8. ⚗️🧍‍♂️ Effects of Silver Nanoparticles of Putranjiva roxburghii on Reproductive Organs in Male Albino Rats

  9. 🌳🧬 Exploring the Impacts of Tecomella undulata Mediated Silver Nanoparticles on Male Rats Fertility and Reproductive Health

  10. 🍀🧫 An In Vitro Antioxidant Potential Analysis of Herbal Silver Nanoparticles Synthesized from Methanolic Leaf Extract of Cassia siamea

🧾 Conclusion:

Based on her scientific contributions, innovative research, and academic merit, Prity Yadav is a highly suitable candidate for the Best Researcher Award. Her work presents a unique and impactful solution to pressing challenges in public health and reproductive medicine. With scope for further growth in collaborative and translational domains, she stands out as a rising researcher making meaningful advances in her field.